BMS-247550

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for BMS-247550, covering 2008-07-24 to 2017-05-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas [Phase 1, Phase 2]